| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Vaxcyte, Inc. | PRESIDENT AND CFO | Common Stock | 62,459 | $2,881,858 | $46.14 | 14 Jan 2026 | Direct |
| Vaxcyte, Inc. | PRESIDENT AND CFO | Common Stock | 61,850 | $2,853,759 | $46.14 | 14 Jan 2026 | Indirect |
| Caribou Biosciences, Inc. | Director | Option to purchase Common Stock | 39,500 | $106,255 | $2.69 | 20 Feb 2024 | Direct |
| Vaxcyte, Inc. | PRESIDENT AND CFO | Stock Option (right to buy) | 121,115 | 07 Apr 2025 | Direct | ||
| Caribou Biosciences, Inc. | Director | Option to purchase Common Stock | 40,500 | 20 Feb 2025 | Direct | ||
| Metacrine, Inc. | Director | Stock Option (right to buy) | 16,500 | 18 May 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PCVX | Vaxcyte, Inc. | 14 Jan 2026 | 2 | $0 | 4 | PRESIDENT AND CFO | 16 Jan 2026, 17:09 |
| PCVX | Vaxcyte, Inc. | 08 Sep 2025 | 1 | -$93,665 | 4 | PRESIDENT AND CFO | 10 Sep 2025, 16:26 |
| PCVX | Vaxcyte, Inc. | 02 Sep 2025 | 3 | -$160,325 | 4 | PRESIDENT AND CFO | 04 Sep 2025, 16:10 |
| PCVX | Vaxcyte, Inc. | 07 Apr 2025 | 2 | +$99,983 | 4 | PRESIDENT AND CFO | 09 Apr 2025, 08:05 |
| PCVX | Vaxcyte, Inc. | 27 Feb 2025 | 4 | -$367,364 | 4 | PRESIDENT AND CFO | 03 Mar 2025, 21:32 |
| CRBU | Caribou Biosciences, Inc. | 20 Feb 2025 | 1 | $0 | 4 | Director | 21 Feb 2025, 20:14 |
| PCVX | Vaxcyte, Inc. | 18 Feb 2025 | 4 | -$628,023 | 4 | PRESIDENT AND CFO | 19 Feb 2025, 18:04 |
| PCVX | Vaxcyte, Inc. | 21 Jan 2025 | 5 | -$649,301 | 4 | PRESIDENT AND CFO | 22 Jan 2025, 18:18 |
| PCVX | Vaxcyte, Inc. | 18 Dec 2024 | 6 | -$667,449 | 4 | PRESIDENT AND CFO | 19 Dec 2024, 16:07 |
| PCVX | Vaxcyte, Inc. | 18 Nov 2024 | 5 | -$643,718 | 4 | PRESIDENT AND CFO | 19 Nov 2024, 16:43 |
| PCVX | Vaxcyte, Inc. | 07 Nov 2024 | 2 | $0 | 4 | PRESIDENT AND CFO | 08 Nov 2024, 20:47 |
| PCVX | Vaxcyte, Inc. | 25 Oct 2024 | 2 | +$399,930 | 4 | PRESIDENT AND CFO | 28 Oct 2024, 17:11 |
| PCVX | Vaxcyte, Inc. | 18 Oct 2024 | 10 | -$4,621,808 | 4 | PRESIDENT AND CFO | 22 Oct 2024, 16:11 |
| PCVX | Vaxcyte, Inc. | 18 Sep 2024 | 5 | -$884,751 | 4 | PRESIDENT AND CFO | 19 Sep 2024, 17:48 |
| PCVX | Vaxcyte, Inc. | 03 Sep 2024 | 1 | -$698,021 | 4 | PRESIDENT AND CFO | 05 Sep 2024, 17:18 |
| PCVX | Vaxcyte, Inc. | 19 Aug 2024 | 4 | -$585,850 | 4 | PRESIDENT AND CFO | 20 Aug 2024, 16:49 |
| PCVX | Vaxcyte, Inc. | 18 Jul 2024 | 6 | -$606,525 | 4 | PRESIDENT AND CFO | 22 Jul 2024, 16:03 |
| PCVX | Vaxcyte, Inc. | 18 Jun 2024 | 4 | -$532,575 | 4 | PRESIDENT AND CFO | 20 Jun 2024, 20:30 |
| PCVX | Vaxcyte, Inc. | 20 May 2024 | 4 | -$557,109 | 4 | PRESIDENT AND CFO | 22 May 2024, 17:03 |
| PCVX | Vaxcyte, Inc. | 18 Apr 2024 | 4 | -$447,399 | 4 | PRESIDENT AND CFO | 22 Apr 2024, 16:42 |
| PCVX | Vaxcyte, Inc. | 18 Mar 2024 | 4 | -$509,344 | 4 | PRESIDENT AND CFO | 20 Mar 2024, 16:29 |
| PCVX | Vaxcyte, Inc. | 29 Feb 2024 | 3 | -$271,532 | 4 | PRESIDENT AND CFO | 04 Mar 2024, 21:20 |
| CRBU | Caribou Biosciences, Inc. | 20 Feb 2024 | 1 | $0 | 4 | Director | 22 Feb 2024, 16:57 |
| PCVX | Vaxcyte, Inc. | 20 Feb 2024 | 5 | -$553,432 | 4 | PRESIDENT AND CFO | 22 Feb 2024, 16:30 |
| PCVX | Vaxcyte, Inc. | 18 Jan 2024 | 6 | -$443,079 | 4 | PRESIDENT AND CFO | 19 Jan 2024, 16:17 |
| PCVX | Vaxcyte, Inc. | 18 Dec 2023 | 4 | -$438,617 | 4 | President and CFO | 20 Dec 2023, 16:35 |
| PCVX | Vaxcyte, Inc. | 14 Dec 2023 | 3 | -$768,180 | 4 | President and CFO | 18 Dec 2023, 16:01 |
| PCVX | Vaxcyte, Inc. | 20 Nov 2023 | 4 | -$366,263 | 4 | President and CFO | 22 Nov 2023, 16:51 |
| PCVX | Vaxcyte, Inc. | 18 Oct 2023 | 4 | -$324,500 | 4 | President and CFO | 20 Oct 2023, 16:30 |
| PCVX | Vaxcyte, Inc. | 05 Sep 2023 | 1 | -$181,968 | 4 | President and CFO | 06 Sep 2023, 18:34 |
| PCVX | Vaxcyte, Inc. | 01 Mar 2023 | 3 | -$71,653 | 4 | President and CFO | 03 Mar 2023, 16:09 |
| CRBU | Caribou Biosciences, Inc. | 21 Feb 2023 | 1 | $0 | 4 | Director | 23 Feb 2023, 16:10 |
| PCVX | Vaxcyte, Inc. | 30 Dec 2022 | 3 | +$126,747 | 4 | President and CFO | 04 Jan 2023, 15:30 |
| PCVX | Vaxcyte, Inc. | 19 Sep 2022 | 4 | -$64,313 | 4 | President and CFO | 21 Sep 2022, 18:05 |
| PCVX | Vaxcyte, Inc. | 02 Sep 2022 | 1 | -$122,641 | 4 | President and CFO | 07 Sep 2022, 16:33 |
| PCVX | Vaxcyte, Inc. | 25 Aug 2022 | 9 | -$815,400 | 4 | President and CFO | 29 Aug 2022, 17:46 |
| PCVX | Vaxcyte, Inc. | 18 Aug 2022 | 4 | -$61,735 | 4 | President and CFO | 22 Aug 2022, 16:41 |
| PCVX | Vaxcyte, Inc. | 18 Jul 2022 | 4 | -$59,462 | 4 | President and CFO | 20 Jul 2022, 17:27 |
| PCVX | Vaxcyte, Inc. | 08 Jul 2022 | 3 | -$57,815 | 4 | President and CFO | 12 Jul 2022, 17:12 |
| /report/000120919122048876-guggenhime-andrew-2022-05-18 | Metacrine, Inc. | 18 May 2022 | 1 | $0 | 4 | Director | 06 Sep 2022, 19:21 |
| PCVX | Vaxcyte, Inc. | 18 May 2022 | 4 | -$59,178 | 4 | President and CFO | 20 May 2022, 17:01 |
| PCVX | Vaxcyte, Inc. | 18 Apr 2022 | 3 | -$57,957 | 4 | President and CFO | 20 Apr 2022, 16:55 |
| PCVX | Vaxcyte, Inc. | 18 Mar 2022 | 3 | -$64,408 | 4 | President and CFO | 22 Mar 2022, 16:22 |
| PCVX | Vaxcyte, Inc. | 02 Mar 2022 | 2 | $0 | 4 | President and CFO | 04 Mar 2022, 19:51 |
| PCVX | Vaxcyte, Inc. | 01 Mar 2022 | 3 | -$115,630 | 4 | President and CFO | 03 Mar 2022, 15:39 |
| PCVX | Vaxcyte, Inc. | 23 Dec 2021 | 3 | -$57,815 | 4 | President and CFO | 28 Dec 2021, 15:13 |
| CRBU | Caribou Biosciences, Inc. | 20 Dec 2021 | 1 | $0 | 4 | Director | 21 Dec 2021, 16:25 |
| PCVX | Vaxcyte, Inc. | 18 Nov 2021 | 4 | -$59,446 | 4 | President and CFO | 22 Nov 2021, 15:58 |
| CRBU | Caribou Biosciences, Inc. | 22 Jul 2021 | 0 | $0 | 3 | Director | 22 Jul 2021, 21:00 |
| /report/000120919121035776-guggenhime-andrew-2021-05-24 | Metacrine, Inc. | 24 May 2021 | 1 | $0 | 4 | Director | 25 May 2021, 18:55 |